Moz and Retinoic Acid Coordinately Regulate H3K9 Acetylation, Hox Gene Expression, and Segment Identity  by Voss, Anne K. et al.
Developmental Cell
ArticleMoz and Retinoic Acid Coordinately Regulate
H3K9 Acetylation, Hox Gene Expression,
and Segment Identity
Anne K. Voss,1,2,* Caitlin Collin,1 Mathew P. Dixon,1 and Tim Thomas1,2,*
1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia
2Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3050, Australia
*Correspondence: avoss@wehi.edu.au (A.K.V.), tthomas@wehi.edu.au (T.T.)
DOI 10.1016/j.devcel.2009.10.006SUMMARY
We report that embryos deficient in the histone
acetyltransferase Moz (Myst3/Kat6a) show histone
H3 lysine 9 (H3K9) hypoacetylation, corresponding
H3K9 hypermethylation, and reduced transcription
at Hox gene loci. Consistent with an observed caudal
shift in Hox gene expression, segment identity is
shifted anteriorly, such that Moz-deficient mice
show a profound homeotic transformation of the axial
skeleton and the nervous system. Intriguingly, histone
acetylation defects are relatively specific to H3K9 at
Hox loci, as neither Hox H3K14 acetylation nor bulk
H3K9 acetylation levels throughout the genome
are strongly affected; H4K16 acetylation actually
increases in the absence of Moz. H3K9 hypoacetyla-
tion,Hox gene repression, and the homeotic transfor-
mationcausedby lackofMozareall reversedby treat-
ment with retinoic acid (RA). In conclusion, our data
show that Moz regulates H3K9 acetylation at Hox
gene loci and that RA can act independently of Moz
toestablishspecificHoxgeneexpressionboundaries.
INTRODUCTION
Vertebrates are structured into body segments, which are most
obvious in the vertebral column, but also marked in the nervous
system. In addition, during development structures such as the
head and neck area and the kidneys are segmented. Hox genes
confer body segment identity, first shown in Drosophila mela-
nogaster by mutation or overexpression of one homeotic gene
leading to complete misspecification of body segments such
that, for example, a leg develops in the place of an antenna or
visa versa (Schneuwly et al., 1987; Struhl, 1981). A single ances-
tral Hox gene cluster has undergone multiple rounds of duplica-
tions to form four Hox gene clusters in mammals (Pollard and
Holland, 2000). Consequently, the roles of Hox genes in body
segment identity specification in mammals show some degree
of redundancy. Mutations of Hox genes are partially compen-
sated by the paralogous Hox genes in the other clusters (Condie
andCapecchi, 1994; Fromental-Ramain et al., 1996; Horan et al.,
1995). Therefore, dramatic homeotic transformations as seen in
Drosophila are rare in mammals. While Hox gene mutant pheno-674 Developmental Cell 17, 674–686, November 17, 2009 ª2009 Elstypes clearly demonstrate the roles of Hox genes in body
segment identity specification, they do not resolve how the
Hox gene expression patterns are established and maintained
specifically with respect to segment boundaries.
Homeotic transformations have led to the identification of
regulators of Hox gene expression, proteins of the trithorax
(TrxG) and polycomb group (PcG) (reviewed by Deschamps
and van Nes, 2005; Ringrose and Paro, 2004). It is thought that
TrxG and PcG proteins affect Hox gene expression by modifying
chromatin structure, introducing covalent modifications to the
amino-terminal tails of histones in theHox clusters. PcG proteins
add the transcriptional repression mark trimethylation of lysine
27 of histone 3 (H3K27me3) (Ringrose et al., 2004). In contrast,
TrxG proteins add the transcriptional activation mark trimethyla-
tion of lysine 4 on histone 3 (H3K4me3) (Nakamura et al., 2002).
In this manner PcG and TrxG may repress and activate/maintain
Hox gene expression, respectively (Lachner and Jenuwein,
2002; Ringrose and Paro, 2004). However, it is unclear precisely
how lysine modification by PcG and TrxG proteins leads to
repression and activation of transcription, respectively (Ringrose
and Paro, 2007). Transcriptionally active loci exhibit acetylation
of lysines in the amino-terminal tails of histones (e.g., H3K9ac;
H3K14ac; H4K5ac; H4K16ac) in addition to H3K4me3 (Jenuwein
and Allis, 2001). Therefore, proteins with histone acetyltransfer-
ase activity must be involved in the global regulation of Hox
gene expression. We show here that the MYST protein, mono-
cytic leukemia zinc finger protein (Moz), regulates histone acet-
ylation at Hox gene loci and their expression.
The human MOZ gene was first identified in recurrent
t(8;16)(p11;p13) translocations causing a particularly aggressive
form of acute myeloid leukemia (FAB M4/5) (Borrow et al., 1996).
Subsequently, otherMOZmutations were discovered in leukemia
and myelodysplastic syndrome (Carapeti et al., 1998; Chaffanet
etal., 2000;Esteyriesetal., 2008;Liangetal., 1998).Mouse fetuses
lacking the Moz gene do not have definitive hematopoietic stem
cells as assessed by competitive reconstitution assays, and, as
aconsequence,MozD/D fetusesaredeficient inmultipotentprogen-
itorsandall lineage-specifichematopoieticprogenitors (Katsumoto
et al., 2006; Thomas et al., 2006). Human leukemia cases involving
MOZ translocations and theMozmutant phenotype in mice show
thatMozhasan important role in thedevelopmentof hematopoietic
stem cells and the regulation of hematopoiesis. However, the
molecular mechanism of Moz function is unclear.
The Moz protein has a central MYST histone acetyltransferase
domain, which it shares with the other four mammalian MYSTevier Inc.
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2009). Amino-terminal to this are two plant homeodomain zinc
fingers (PHD) andanamino-terminal NEMMdomain.Moz has car-
boxy-terminal serine- and methionine-rich domains with transac-
tivation properties in vitro (Champagne et al., 2001; Kitabayashi
etal., 2001).MOZcan interactwithacutemyeloid leukemiaprotein
1 (AML1/RUNX1) and with PU.1 and enhances AML1 as well as
PU.1-induced transcriptional activation in vitro (Katsumoto et al.,
2006; Kitabayashi et al., 2001). However, Moz is a widely ex-
pressed gene in adult tissues as well as during development and
is therefore likely to regulate a wide range of biological processes
both within the hematopoietic system and in other cell types.
MOZ can acetylate all core histones in vitro (Champagne et al.,
2001; Holbert et al., 2007; Laue et al., 2008). However, when iso-
lated from HeLa cells as a component of the ING5 tumor
suppressor complex, MOZ shows specificity for H3K14 acetyla-
tion in vitro (Doyon et al., 2006). Another study suggested that
MOZspecifically acetylatesH4K16 (Fraga et al., 2005), indicating
considerable uncertainty as to which lysine residues Moz may
acetylate. Moreover, the preference of Moz for specific lysine
residues in vivo has not been examined and there is no functional
evidence linking histone acetyltransferase function of Moz at
specific lysine residues to transcriptional regulation in vivo.
Mutation of the Moz homolog in zebrafish causes cranial
neural crest development defects (Crump et al., 2006; Miller
et al., 2004). Interestingly, effects of zebrafish moz mutation
are restricted to the head region. In contrast, in mice, as we
report here, mutation of theMoz gene causes an anterior home-
otic transformation of 19 body segments of the neck and trunk
region, a homeotic transformation unusual in extent and
completeness in mammals. The Moz mutant anterior homeotic
transformation was completely rescued by RA treatment. We
show that Moz is required for normal levels of expression of all
Hox genes examined and for the establishment of the correct
anterior expression boundary of Hox genes 50 of the second pa-
ralogous group. Furthermore and in contrast to previous in vitro
data, we found that Moz is essential for H3K9 acetylation in vivo.
RESULTS
Mutation of Moz Causes an Anterior Homeotic
Transformation
MozD/Dmutantmousepups (Thomaset al., 2006) exhibit a hunched
posture and an extended neck region at birth (Figures 1A and 1B).
Examination of skeletal preparations revealed the presence of an
additional 8th cervical vertebra in allMozD/Dmutant pups, whereas
all wild-type and MozD/+ heterozygous pups had the normal
complement of seven cervical vertebrae (Figures 1C–1F; n = 10
MozD/D mutant and 11 wild-type pups). The additional cervical
vertebra had the morphology of a supernumerary first vertebra,
the atlas (Figures 1G and 1H). In the MozD/D mutants the first and
the secondary atlas shared one common enlarged anterior arch
of the atlas (Figures 1C and 1D). The shift in axial skeleton segment
identity in the MozD/D mutants was perpetuated throughout the
cervical and thoracic vertebrate column, such that the 8th vertebra,
which is ordinarily the first rib-bearing thoracic vertebra, acquired
the morphology of the seventh cervical vertebra. Occasionally it
had small bones attached to its ventral side. Smaller rudimentary
ribs have been observed at the 7th cervical vertebra in 40% ofDevelopmwild-type pups (Kessel and Gruss, 1991). The 9th vertebra, which
forms the second thoracic vertebra in wild-types and MozD/+
heterozygotes, was the first vertebra in the MozD/D mutants
carrying a normal rib with contact to the sternum (Figures 1G and
1H).MozD/Dmutantsexhibitedonly 12 rib-bearing thoracic vertebra
as compared to the normal complement of 13 in wild-types and
MozD/+ heterozygotes, such that the first lumbar vertebra is the first
vertebracorrectly specified in theMozD/Dmutants (datanotshown).
Paralleling the additional cervical axial skeleton segment, we
observed an additional cervical segment in the nervous system.
E10.5 embryos stained for neurofilament marked 3 occipital, 7
cervical, 13 thoracic, and also lumbar and caudal intersegmental
nerves clearly in thewild-type (Figure 1I). The first intersegmental
nerve contributing to the innervation of the forelimb is the 7th
intersegmental nerve, which corresponds to the 4th cervical
nerve. In contrast, the 8th intersegmental nerve was the first
that contributed to the innervation of the forelimb in MozD/D
mutant embryos (Figure 1J, n = 6 wild-type and 6MozD/Dmutant
embryos). In the wild-types the first 4 intersegmental nerves
contributed to the hypoglossal nerve (Figure 1K). In contrast in
the MozD/D mutants, the first 5 intersegmental nerves contrib-
uted to the hypoglossal nerve (Figure 1L). Interestingly, the
effects of Moz were surprisingly specific to the process of deter-
mining body segment identity given the widespread expression
of the Moz gene (see Figure S1 online).
Our data show that Moz deficiency results in a complete ante-
rior homeotic transformation affecting C2 to T13 unusual in its
completeness for mammals or vertebrates in general.
Moz Regulated Hox Genes Globally
The anterior homeotic transformation suggested that Moz either
regulatedHox gene expression or acted as a transcriptional core-
gulator for Hox proteins. The extent and completeness of the
homeotic transformation suggested that loss of Moz affected
the function of a large number ofHoxgenes or proteins.Weexam-
inedHoxgenesof theAandof theBcluster, namely,Hoxa1,a2,a3,
a4, a5, and a6, and Hoxb2, b3, b4, b5, b6, and b8. We observed
that all Hox genes examined were expressed at lower levels in
the MozD/D mutant embryos as compared to wild-type controls
by whole-mount in situ hybridization (Figures 2 and 3; n = 72
MozD/D mutant embryos and 72 wild-type embryos). The differ-
ence was particularly prominent in Hoxa1, Hoxa3, Hoxb3, and
Hoxb4 (Figure 2A versus Figure 2B, Figure 2E versus Figure 2F
and Figure 3C versus Figure 3D, Figure 3E versus Figure 3F).
Importantly, we observed a shift in the anterior expression
boundary of all Hox genes 50 of the second paralogous group.
While the expression domains of Hoxa1, Hoxa2, and Hoxb2
were not altered, the expression domains of Hoxa3 to Hoxa6
(Figure 2), Hoxb3 to Hoxb6, and Hoxb8 (Figure 3) were shifted
by at least one body segment both in the paraxial mesoderm
and in the nervous system (summarized in Figure 4A and
Figure S2; n = 6MozD/Dmutant embryos and 6wild-type embryos
per gene). As the expression levels ofHoxb4were too low inmost
MozD/D mutant embryos to determine the anterior expression
boundary, we examined Hoxb4 protein and observed the shift of
the anterior expression boundary at the protein level (Figures 3M
and 3N; n = 6MozD/Dmutant embryos and 6 wild-type embryos).
Generally, the levels of Hox gene expression were more
uniform among the wild-type embryos than in theMozD/Dmutantental Cell 17, 674–686, November 17, 2009 ª2009 Elsevier Inc. 675
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Moz Is Required for H3K9ac at Hox Gene ClustersFigure 1. MozD/D Pups Have an Anterior Homeotic Transformation
of the Axial Skeleton and the Nervous System
E18.5 (A–H) and E10.5 (I–L) wild-type (A, C, E, G, I, and K) andMozD/D (B, D, F,
H, J, and L). Shown are the external appearance (A and B) and skeletal prep-
arations of the cervical vertebrae column: lateral view (C and D), dorsal view (E
and F), and axial, rostral view of individual cervical vertebra (G and H). Neuro-
filament immunostaining displays the segmental nerves along the body axis
(J–L). Note the hunched posture and elongated neck region (bracket in [B]
versus [A]).MozD/Dmutant pups have eight instead of seven cervical vertebrae
(C–H). The additional cervical vertebra is most similar to the morphology of the
atlas (C, D, G, and H). The first and the supernumerary atlas share one enlarged
anterior arch of the atlas (solid arrows in [D] versus [C]). The identities of all
other cervical vertebrae are shifted to anterior by one segment (G and H).
The tuberculum anterior is absent in the MozD/D (stippled arrow in [C] and
[D]). In someMozD/D pups additional arches or partial arches of supernumerary676 Developmental Cell 17, 674–686, November 17, 2009 ª2009 Elsembryos andwere almost undetectable in someMozD/Dmutants
(e.g., Figures 3D and 3F). Quantitation of Hoxa3, Hoxa4, Hoxb3,
and Hoxb4 mRNA by northern blot and densitometry at E9.5,
E10.5 (Figure 4B), and E11.5 (Figures 4C and 4D) revealed an
overall reduction in expression of these Hox genes in MozD/D
mutant embryos by approximately one half. Analysis of three
to five E11.5 embryos per genotype showed that the reduction
in Hox gene expression was statistically significant (p < 0.0001)
and that Hoxb3 and Hoxb4 mRNA was present in heterozygous
MozD/+ embryos at levels intermediate between wild-type and
MozD/D homozygous embryos (Figure 4D).
Examining if Hox gene expression was initiated normally in
Moz/ mutant embryos using the example of Hoxa3, we found
that Hoxa3 expression was very low or undetectable in E7.5
Moz/ mutant embryos as compared to controls and did not
reached normal levels of expression at later stages (Figures
4E–4J; n = 8 Moz/ mutants and 9 littermate controls).
Our results show a global effect of Moz deletion on Hox gene
expression and specification of the anterior expression boundary
of Hox genes.
H3K9 Is Hypoacetylated and Hypermethylated
at Hox Gene Loci in the Absence of Moz
To assess the effects of Moz deficiency on histone acetylation in
E10.5 embryos, we determined the association of regions of the
Hoxa and the Hoxb gene clusters (Figure 5A) with acetylated
histones by chromatin immunoprecipitation using antibodies
against acetylated H3K9 and H3K14 followed by quantitative
genomic PCR. As H3K9 can be either acetylated (associated
with transcription) or methylated (associated with silencing),
we also examined H3K9 trimethylation levels. Data are pre-
sented normalized for the housekeeping gene beta-2-microglo-
bulin for the activation marks (H3K9ac and H3K14ac) and for the
transcriptionally repressed genes albumin and hemoglobin beta
1 for the silencingmark (H3K9me3) within samples (n = 6mutants
and 6 controls for H3K9ac and H3K14ac; 3 mutants and 3
controls for H3K9me3). Based on the work of Doyon et al.
(2006), we expected that H3K14 acetylation might be reduced
in the absence of Moz and that H3K9 acetylation might be
unchanged. Contrary to this expectation, we found that overall
association of Hox gene sequences with acetylated H3K9 was
significantly reduced in the Moz mutant embryos (Figures 5B–
5E; p < 0.0001). Specifically, we found that genomic sequences
significantly underrepresented in the Moz mutant anti-H3K9ac
atlases can be observed (asterisk in [F] versus [E]). The first nerve contributing
to the innervation of the forelimb is the 7th intersegmental nerve in the wild-
type and the 8th in theMozD/D (arrowheads in [J] versus [I]). The first five inter-
segmental nerves contribute to the hypoglossal nerve (XII) in MozD/D as
compared to the first four in wild-type (arrowheads in [L] versus [K]). I–XII,
1st to 12th cranial nerve; 1–8, 1st to 8th intersegmental nerve; aaa, anterior
arch of the atlas; At, Atlas; At’, supernumerary atlas; Ax, axis; C3–C7, 3rd to
7th cervical vertebrae; Ax’, C40–C80, axis and C4 to C8 in the MozD/D (prime
indicates that these differ from the wild-type vertebrae); Eo, exooccipital
bone; FB, forebrain; FL, forelimb; HB, hyoid bone; He, heart; PA1, PA2, 1st,
2nd pharyngeal arch; R1–R3, 1st to 3rd rib; Rh2–Rh7, rhombomeres 2 to 7;
T1, T10, 1st thoracic vertebra; ta, tuberculum anterior; TR, tympanic ring; S1,
1st bone segment of the sternum; So, supraoccipital bone. Scale bar equals
2.5 mm in (A) and (B), 1.9 mm in (C) and (D), 0.6 mm in (E) and (F), 1.3 mm
(G) and (H), 500 mm in (I) and (J), and 300 mm in (K) and (L).evier Inc.
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Moz Is Required for H3K9ac at Hox Gene ClustersFigure 2. MozD/D Show Reduced Expression of all Hoxa Cluster
Genes and a Posterior Shift in Hoxa Gene Expression from the 3rd
Gene Onward
Wild-type (A,C,E,G, I, andK)andMozD/D (B,D,F,H, J, andL) atE8.5 (AandB)and
E10.5 (C–L). In situ hybridization detected Hoxa1 to Hoxa6 mRNA as indicated.
E10.5 sense control experiments did not produce a signal (data not shown).
Note the weaker signal in theMozD/D, in particular Hoxa1 (arrows [B] versus [A])Developmprecipitate comprised the start of transcription ofHoxa4,Hoxb3,
and Hoxb4 (Figure 5B), the sequences 0.7 to 1.5 kb upstream of
the start of transcription of Hoxa4 and Hoxb4 (Figure 5C), the
coding regions (Figure 5D), and two putative retinoic acid
response elements (RARE; Figure 5A and Table S1) each near
the Hoxa3 and Hoxb3 loci (Figure 5E). Exact p values for the
specific genomic sites examined by ChIP (Figure 5) are given
in Table S2. While H3K9 hypoacetylation at the Hox loci was
prominent, global levels of H3K9 acetylation were not signifi-
cantly different in Moz/ mutant, Moz/+ heterozygous, and
wild-type embryos as assessed by immunoblotting and densi-
tometry (Figures 5F and 5G; n = 3 embryos per genotype, 1 indi-
vidual embryo per lane, p = 0.7109).
Mirroring the reduction in H3K9 acetylation, we observed an
increase in H3K9me3 in Moz/ mutant E10.5 embryos as
compared to wild-type controls (Figures 5H and 5I; p = 0.0004).
In contrast to H3K9ac, levels H3K14 acetylation were not signifi-
cantly different between Moz/ mutants and controls (Figures
5J–5M; p = 0.7155).
The differential effect on H3K9 and H3K14 acetylation
suggests that the observed loss of histone acetylation at Hox
loci is not merely a downstream consequence of transcriptional
repression, but a direct and specific effect, as Moz deficiency
does not affect all histone marks corresponding to gene activa-
tion at Hox loci. Overall our data indicate that in E10.5 mouse
embryos Moz is required for normal levels of H3K9 acetylation
across the Hoxa and the Hoxb gene clusters and has no or
very limited effects on H3K14 acetylation.
Retinoic Acid Treatment Rescues the Moz Mutant
Body Segment Identity Defect
Retinoic acid (RA) is a potent activator of Hox gene expression.
Oversupply of RA or vitamin A leads to birth defects in humans
(Geelen, 1979). In experimental settings, RA treatment of preg-
nantmice activates stronger aswell as ectopicHox gene expres-
sion in the developing embryos and causes homeotic transfor-
mations (Kessel and Gruss, 1991).
As the anterior homeotic transformation in Moz mutants was
the opposite phenomenon to the posterior homeotic transforma-
tion after treatmentwithRAat E7, a connection betweenMozand
RA in body segment identity specification was possible. There-
fore, we examined the effects of RA treatment on the Moz-defi-
cient body segment identity defect (Figure 6; n = 11 MozD/D
homozygous, 12 MozD/+ heterozygous, and 15 wild-type pups).
Treatment of pregnant females with 10 mg/g bodyweight RA at
E7.25 caused a posterior homeotic transformation in 8 of 9
wild-type pups, which developed only 6 cervical vertebra
(Figures 6C and 6E), as reported previously (Kessel and Gruss,
1991). Notably, RA treatment at 10 mg/g completely rescued
the Moz-deficient body segment identity defect in 6 of 6MozD/D
mutant pups (Figures 6D and 6E). In one MozD/D mutant pup,
and Hoxa3 ([F] versus [E]). The anterior expression boundary in the neural tube
is indicated (arrows in [E] and [F], dotted lines in [I]–[L], distance from the otic
vesicle in [G] and [H]). Very weak expression of Hoxa2 in the 3rd rhombomere in
MozD/D is indicated (R3 in D versus C). 1a, 1b, maxillary and mandibular part of
the 1st pharyngeal arch; 2, 3, 2nd and 3rd pharyngeal arch; d, prevertebrae; *,
otic vesicle. Scale bars equal 550 mm in (A) and (B), 455 mm in (C), (D), (K) and
(L), 755 mm in (E) and (F), 1.2 mm in (G) and (H), and 485 mm in (I) and (J).ental Cell 17, 674–686, November 17, 2009 ª2009 Elsevier Inc. 677
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Moz Is Required for H3K9ac at Hox Gene ClustersRA overcompensated for the Moz defect (Figure 6E). A reduced
RA dose of 5 mg/g rescued the Moz mutant phenotype in 4 of 5
MozD/Dmutant embryos (Figure 6E). Interestingly,MozD/+ hetero-
zygous embryos showed a response intermediate between wild-
type and MozD/D homozygous embryos. One half of the MozD/+
heterozygous embryos receiving 10mg/gRAhad7 cervical verte-
brae and the other half had 6 cervical vertebrae (Figure 6E).
Finally, RA treatment was required during a specific period on
embryonic day 7, as treatment at E8.5 did not rescue the Moz
mutant phenotype (data not shown).
RA treatment at E7.25 resulted in stronger expression ofHoxa1
at E8.5 in MozD/D mutant embryos than in wild-type controls
(Figure S3), which stood in stark contrast to the usual low levels
ofHox gene expression inMozD/Dmutant embryos without treat-
ment. However, growth retardation by approximately 12 hr at
E8.5, which was more severe in wild-type embryos than in
MozD/D mutant embryos, was observed after RA treatment,
which complicated the analysis.
Gene expression levels for the rate-limiting enzyme in RA
synthesis,Raldh2, and the retinoic acid receptors alpha (RARa) and
betawere indistinguishable inMozD/Dmutant embryosandcontrols
(data not shown; n = 6 MozD/D mutant embryos and 6 wild-type
embryo per gene). Furthermore, nuclear translocation of the RARa
Figure 3. MozD/D Show Reduced Expres-
sion of All Hoxb Cluster Genes and a Poste-
rior Shift in Hoxb Gene Expression from the
3rd Gene Onward
E10.5 wild-type (A, C, E, G, I, K, andM) andMozD/D
(B,D, F,H, J, L, andN). In situ hybridization (A–L)de-
tecting Hoxb2 to Hoxb6 and Hoxb8mRNA as indi-
cated. Note the weaker signal in the MozD/D, in
particular Hoxb3 (C and D) and Hoxb4 (F] versus
[E]). Hoxb4 protein distribution is shown (M and
N). The anterior expression boundary in the neural
tube is indicated (arrows in [A]–[D], dotted lines in
[E], [F], and [I]–[L], and distance from the otic vesicle
in [G], [H], [M], and [N]). Labeling is as in Figure 2.
Scale bar equals 1.1 mm in [A]–[D], 390 mm in [E],
[F], [M], and [N], 725 mm in [G] and [H], 340 mm in
[I] and [J], and 390 mm in [K] and [L].
protein occurred normally in the reported
RA signaling domain (data not shown; n =
3MozD/Dmutant embryos and 3 wild-type
embryos). Therefore, Moz is not required
for RAR expression or nuclear transloca-
tion. We conclude that essential elements
ofRAsignalingarenormal inMozD/Dmutant
embryos. Furthermore, RA signaling
rescues the Moz mutant body segment
identity defect in the absence of Moz, sug-
gesting that RA acts in parallel to Moz to
define body segment identity.
Retinoic Acid Treatment Restores
H3K9 Acetylation at Hox Gene Loci
in Moz Mutants
As RA rescued the Moz mutant segment
identity defect (Figure 6) and Hox gene
expression (Figure S3), we predicted that RA would rescue
the deficiency in histone acetylation in Moz mutant embryos.
Indeed, H3K9 acetylation returned to normal levels in E10.5
Moz/ mutant embryos that were treated with RA at E9.5
(Figure 7; n = 5 RA-treated Moz mutants, 4 RA-treated wild-
type controls, 5 untreated Moz mutants and 4 untreated wild-
type control embryos). As in our previous series of experi-
ments, H3K9ac was reduced in untreated Moz/ mutant
embryos as compared to controls at sites upstream of the start
of transcription of Hoxa4 and Hoxb4 (Figure 7A) and at the
RARE (Figure 7B). RA treatment resulted in a significant
increase in H3K9ac in Moz/ mutants embryos (p < 0.0001)
such that the levels were no longer significantly different from
controls upstream of the start of transcription (Figure 7C
versus Figure 7A) and at RARE (Figure 7D versus Figure 7B).
Exact p values for individual genomic sites are displayed in
Table S3.
In contrast to H3K9 acetylation, H3K14 acetylation was neither
affected by the absence ofMoz (Figure 7F), nor by treatment with
RA (Figure 7G), indicating that not all acetylation marks are regu-
lated by Moz and RA.
Surprisingly,weobserved thatH4K16acetylationwas increased
inMoz/mutant embryos comparedwith controlswith orwithout678 Developmental Cell 17, 674–686, November 17, 2009 ª2009 Elsevier Inc.
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Moz Is Required for H3K9ac at Hox Gene ClustersRA treatment (Figures 7I and 7J). RA had no effect on H4K16ac
(Figure 7J versus Figure 7I).
Considering levels of H3K9, H3K14, and H4K16 acetylation
at all Hox sites examined, we can conclude that H3K9ac is
reduced in the absence of Moz (Figure 7E; p < 0.0001) and
restored to normal by RA (Figure 7E; p < 0.0001), while
H3K14ac at all sites is neither affected by Moz nor by RA
(Figure 7H; p = 0.2096 and p = 0.4595, respectively) and
H4K16ac is increased in the absence of Moz (Figure 7K; p <
0.0001) and not influenced by RA treatment in wild-type or
Moz/ mutants (Figure 7K; p = 0.2861). The data show
that Moz specifically acetylates H3K9 and demonstrate
Figure 4. HoxGeneExpression in theMozD/D
Assessed by Whole-Mount In Situ Hybrid-
ization and Northern Blot
(A) Diagram of the developing axial skeleton from
the 1st occipital to the 9th thoracic segment.
Bars show the anterior extent of Hox gene expres-
sion domains in the paraxial mesoderm at E10.5.
Data are shown of a total of 60 wild-type and
60 MozD/D embryos, 6 of each genotype for each
probe. Note the shift by at least one segment
posterior from the 3rd paralogous group onward
(Hoxa3, Hoxb3, and more posteriorily expressed
Hox genes). Shaded area indicates the first
segment, which lost expression of both paralo-
gous genes of Hox clusters A and B. The identity
of this segment is duly shifted anteriorily (C2/
C1).
(B–D) Quantitation of the reduction in Hox gene
expression in MozD/D and controls by northern
blot analysis of pooled E9.5 and E10.5 embryos
(B) and of individual E11.5 embryos followed by
densitometry (C and D) shows an approximately
2-fold reduction in expression of Hoxa3, Hoxa4,
Hoxb3, and Hoxb4 (n = 3 to 5 E11.5 embryos per
genotype; p < 0.0001). Data are presented and
were analyzed as described in the Experimental
Procedures. Error bars show SEM. p values of
<0.01 and <0.001 are indicated with two and three
asterisks, respectively. At E7.5 Hoxa3 expression
was very low or undetectable in Moz/ mutants
as compared to controls ([E] and [F] versus [H]
and [I]) and did not reach the same extent and
intensity (G and J). PS, primitive streak; asterisks
in (H) and (K) indicate somites; the arrow indicates
the hindbrain expression domain of Hoxa3 detect-
able in the wild-type. Bars equal 180 mm in (F), (G),
(I), and (J) and 200 mm in (H).
the ability of RA to specifically rescue
H3K9 acetylation in Moz-deficient
embryos.
Ing5, a Moz Protein Complex
Component, Occupies Hox Loci
When Moz Is Present
Human MOZ has been shown to be
a part of the ING5 tumor suppressor
complex in HeLa cells (Doyon et al.,
2006). We observed that mouse Ing5
associated with Hox gene loci in the presence, but not in the
absence, of Moz (Figure 7L; all Hox sites p < 0.0001). RA treat-
ment failed to rescue Ing5 association with Hox loci in Moz
mutants (Figures 7M and 7N; p = 0.0013; Table S3). These
data show that Moz is required for Ing5 recruitment to and/or
tethering at Hox loci.
Mll1 Association with Hox Loci Is Reduced
in the Absence of Moz
The TrxG gene Mll1 is required for Hox gene expression, and
mutation of Mll1 leads to an anterior homeotic transformation
similar in extent and severity to the anterior homeoticDevelopmental Cell 17, 674–686, November 17, 2009 ª2009 Elsevier Inc. 679
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order to address a possible functional link between Moz
and Mll1, we assessed occupancy of Hox loci by Mll1 in
Moz/ mutant embryos and controls. Individual Hox sites
showed a tendency or a mildly significant decrease in associ-
ation with Mll1 (Figure 7O), which resulted in a significant
reduction in association of Mll1 in the absence of Moz when
considering all Hox sites together (Figure 7P; all Hox sites p =
0.0001; Table S3).
The observation that the absence of Moz results in reduced
association of Mll1 with Hox gene loci and reduced Hox gene
expression suggests that Moz or H3K9 acetylation may recruit
Mll1 to Hox gene loci.
Figure 5. H3K9 Hypoacetylation and Hyper-
methylation at Hox Loci in Moz/ Embryos
(A) Genomic region examined for histone modifica-
tions and protein binding by ChIP/qPCR.
‘‘Hoxa3_1’’, ‘‘Hoxa4_1’’, ‘‘_2,’’ etc denote
sequences amplified in (B)–(M) and Figure 7.
H3K9ac (B–E), H3K9me3 (H and I) and H3K14ac
(J–M) were assessed by ChIP of lysates of Moz/
mutant and wild-type E10.5 embryos followed by
qPCR of sequences spanning the start of transcrip-
tion ([B, H, and J], tile_1), 0.7 to 1.5 kb 50 of the start
of transcription ([C, H, and K], tiles_2 and _3), in
the protein coding regions ([D and L], cds), and at
putative RARE (E and M). Data are derived from
a total of 30 embryos, 6 of each genotype for
H3K9ac and H3K14ac, 3 of each genotype for
H3K9me3. Note the reduction in H3K9ac in
Moz/ mutant embryos at Hox loci overall ([B–
E], overall p < 0.0001) and the corresponding
increase in H3K9me3 ([H and I], overall p =
0.0004), but the lack of an effect on H3K14ac
([J–M], overall p = 0.7155). (F and G) Global
H3K9 acetylation as assessed by immunoblotting
(F) and densitometry (G) was not significantly
different in the three genotypes (Mr 17 kDA; p =
0.7109; n = 3 E10.5 embryos per genotype; 1 indi-
vidual embryo per lane). Data are presented and
were analyzed as described in the Experimental
Procedures. Error bars represent SEM. For the
effect of Moz genotype, p values <0.05, <0.01,
and <0.001 are indicated with one, two, and three
asterisks, respectively. Exact p values are given in
Table S2.
DISCUSSION
The MYST histone acetyltransferase MOZ
is the target of recurrent translocations
causing a particularly aggressive form of
acute myeloid leukemia (Borrow et al.,
1996; Carapeti et al., 1998; Liang et al.,
1998), andMoz is required for thedevelop-
ment of hematopoietic stem cells (Katsu-
moto et al., 2006; Thomas et al., 2006).
Here we have shown that Moz is required
for normal levels of H3K9 acetylation and
gene expression at a large number of Hox
loci and for identity specification of 19
body segments of the cervical and thoracic axial skeleton and
nervous system. Interestingly, the anterior homeotic transforma-
tion,Hox gene expression, andH3K9 acetylationwere completely
rescued by treatment ofMozmutant embryos with retinoic acid.
FunctionalComparisonofMouseMozandZebrafishMoz
Our study revealed surprising differences in Moz function in
mouse and zebrafish. There is a much more extensive require-
ment forMoz to activateHox gene expression inmouse embryos
(our data presented here) than in zebrafish (Crump et al., 2006;
Miller et al., 2004). The lack of an effect on more posterior hox
genes is commensurate with restricted expression of moz in
the zebrafish head (Miller et al., 2004). However, the lack of an680 Developmental Cell 17, 674–686, November 17, 2009 ª2009 Elsevier Inc.
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by nonoverlapping expression domains and suggests a clear
difference in the function of Moz in mice and zebrafish. Effects
of the zebrafishmozmutation are restricted to the cranial neural
crest and the second to fourth pharyngeal arch (Crump et al.,
2006; Miller et al., 2004). In contrast, Moz mutant mice show
identity defects in a total of 19 body segments extending over
the cervical and thoracic region. Conversely, unlike in zebrafish,
the second pharyngeal arch and the cranial nerves I–XI are
unchanged inmouseMozmutants. Thismay be due to functional
Figure 6. Retinoic Acid Treatment Rescues theMozD/DMutant Body
Segment Identity Defect
Skeletal preparations of wild-type (A and C) andMozD/D (B and D) E18.5 pups.
Damswere treated at E7.25with peanut oil (A and B) or 10 mg/g bodyweight RA
in peanut oil (RA, [C and D]). Note the supernumerary cervical vertebra in the
peanut-oil-treatedMozD/D ([B] versus [A]), as seen in untreated pups (Figure 1),
and the rescue of the cervical vertebrae in the RA-treated MozD/D ([D] versus
[C] and [A]), as well as the reduction of the number of cervical vertebrae to
six in the RA-treated wild-type ([C] versus [A]). (E) Enumeration of skeletal
preparations. The effects of RA on MozD/D (rescue), on wild-type (reduction
to six cervical vertebrae), and onMozD/+ heterozygote (reduction to six cervical
vertebrae in half the cases) was statistically significant with p < 0.0001,
p < 0.0001, and p = 0.009, respectively. Data were analyzed as described in
the Experimental Procedures. Labeling as in Figure 1. The scale bar equals
0.6 mm.Developmredundancy between Moz and the closely related MYST protein
Qkf/Morf/Kat6b, which is particularly strongly expressed in head
structures during mouse development (Thomas et al., 2000).
Moz and Qkf share all functional domains and have greater
than 90% similarity in their PHD, MYST, and serine-rich domains
(Thomas et al., 2000). Thus, Qkf may substitute partially for the
loss of Moz in head structures.
Moz and Retinoic Acid in Hox Gene Regulation
The anterior homeotic transformation in Moz mutants observed
here is opposite to the posterior homeotic transformation
caused by teratogenic treatment with RA (Kessel and Gruss,
1991). RA is a potent, global activator of Hox gene expression.
Oversupply of RA or vitamin A leads to birth defects in humans
(Geelen, 1979). RA is produced by the developing embryo
(Hogan et al., 1992) and degraded by Cyp26 to generate specific
RA levels along the rostro-caudal body axis (Sakai et al., 2001).
RA acts through retinoic acid receptors (RAR), which are ex-
pressed in partially overlapping patterns along the rostro-caudal
axis of the embryo (Dolle et al., 1990; Ruberte et al., 1991). RAR
translocate to the nucleus, where they binds to retinoic acid
response elements (RARE). A number of RARE within the
Hox clusters have been functionally verified in vivo by showing
that Hox gene RARE reporter transgenes recapitulate the
specific anterior expression boundary of the original Hox gene
in vivo (Dupe et al., 1997; Gould et al., 1998; Huang et al.,
2002; Marshall et al., 1994; Packer et al., 1998; Zhang et al.,
2000).
Interestingly, we found that the elements of the RA signaling
pathway functioned in the absence of Moz. However, the
MOZ-TIF2 fusion protein, which causes leukemia, downregu-
lates the transcription of the RARb gene (Collins et al., 2006).
The absence of an effect of Moz deficiency on RARb gene
expression suggests that the oncogenic MOZ-TIF2 fusion
protein has acquired an ectopic function. In contrast,RAR genes
are expressed normally and RAR translocates into the nucleus
normally in Moz mutant embryos. Most importantly, the Moz
mutant segment identity defect is rescued by RA treatment.
This shows that at least exogenous RA can act through its recep-
tors and activate Hox gene expression in the absence of Moz.
Moz, Polycomb Group, and Trithorax Group Proteins
in Hox Gene Regulation
PcG proteins act in multiprotein complexes, the polycomb
repressor complexes. They add the repressive histonemodifica-
tion H3K27me3 and are required to maintain repression of Hox
genes. Mutations of proteins of the polycomb complex cause
deregulation of Hox gene expression and posterior homeotic
transformations, as seen for example in Bmi1, Mel18, and Eed
mutants (Akasaka et al., 1996; Schumacher et al., 1996; van
der Lugt et al., 1994). The polycomb group protein Eed associ-
ates with histone deacetylase activity (van der Vlag and Otte,
1999), the enzymatic activity directly opposing the action of
histone acetyltransferases. Mutations of polycomb complex
proteins and mutation of Moz cause opposite effects: posterior
versus anterior homeotic transformation; deregulation of Hox
gene activity versus loss of Hox gene activity.
Directly opposing the function of polycomb repressor
complexes, proteins of the trithorax group (TrxG) add the histoneental Cell 17, 674–686, November 17, 2009 ª2009 Elsevier Inc. 681
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H3K4me3. Like mutations of the Moz gene, mutations of TrxG
genes lead to hematopoietic malignancies. The anterior home-
otic transformation that we observed in the Moz mutants is
rivaled in completeness and extent only by mutation of the
Mll1 gene (Yu et al., 1995). We show here that not only is Moz
required for normal Hox gene expression and body segment
identity specification, like TrxG proteins, but Moz is also required
for the association of Mll1 with Hox gene loci in vivo. Indeed,
the SET domain of MLL1 binds with preference to H3 when
Figure 7. Retinoic Acid Treatment ofMoz/
Mutants at E9.5 Restores H3K9 Acetyla-
tion at E10.5, and Recruitment of Ing5
and Mll1 Are Dependent on Moz
E10.5 embryos were used for ChIP experiments
(A–P) as in Figures 5O and 5P) or after treatment
of the pregnant females with vehicle (peanut oil)
or RA at E9.5. H3K9 (A–E), H3K14 (F–H), and
H4K16 (I–K) acetylation and Ing5 (L–N) and Mll1
association (O and P) were assessed at a subset
of the genomic Hox sites examined in Figure 5.
Effects summarized over all genomic sites are dis-
played (E, H, K, N, and P). Note the reduction in
H3K9ac in Moz/ mutants without RA as
compared to controls (A, B, and E) and the similar
levels of H3K9ac after RA treatment (C, D, and E),
whereas H4K16ac is increased inMoz/mutants
and not affected by RA treatment (I–K). In contrast
to H3K9ac and H4K16ac, H3K14ac is generally
not different between Moz/ mutants and
controls irrespective of RA (F–H). Note the very
low levels of Ing5 association with Hox loci in
Moz/ mutants as compared to controls (L and
N). RA treatment did not rescue the levels of Ing5
at Hox loci in Moz/ mutants (M and N). Note
the reduction in the TrxG protein Mll1 at Hox loci
in Moz/ mutants as compared to controls (O
and P). For the effect of Moz genotype, p values
are indicated as in Figure 5, and exact p values
are in Table S3. Error bars represent SEM.
acetylated at K9 (and K14), whereas
H3K9methylation reduces its association
with H3 in vitro (Katsani et al., 2001).
Moreover, H3 peptide acetylated at
H3K9 stimulates the H3K4-methyltrans-
ferase activity of the MLL1 SET domain
in vitro (Milne et al., 2002). Together,
these results suggest a complex interplay
between H3K9 acetylation and H3K4
methylation.
Moz-Specific Histone Acetylation
Marks
MOZ has been reported to acetylate
histones H2A, H2B, H3, and H4 in the
form of free histones in vitro (Champagne
et al., 2001; Holbert et al., 2007; Laue
et al., 2008). MOZ can acetylate lysines
5, 8, 12, and 16 of histone H4 and lysine
14 of histone H3 in vitro (Kitabayashi
et al., 2001). Specific histone residues put forward as preferential
targets of MOZ include H4K16 when comparing normal lympho-
cytes to leukemia cells (Fraga et al., 2005) and H3K14 in HeLa
cell extracts (Doyon et al., 2006). H3K9 was previously ruled
out as a MOZ acetylation target (Doyon et al., 2006). However,
our comparison of H3K9, H3K14, and H4K16 acetylation in the
Moz-replete and Moz-deficient embryos shows that Moz is
required specifically for H3K9 acetylation at Hox loci in vivo.
H3K9 acetylation was reduced by approximately one half
in Moz mutants, suggesting the presence of another H3K9682 Developmental Cell 17, 674–686, November 17, 2009 ª2009 Elsevier Inc.
Developmental Cell
Moz Is Required for H3K9ac at Hox Gene Clustersacetyltransferase, possibly the closely related Qkf protein with
which Moz shares all functional domains.
Remarkably, RA treatment restored H3K9 acetylation levels
and Hox gene expression levels in the Moz mutant embryos.
Although the identity of the histone acetyltransferase activity
that acetylates H3K9 specifically at Hox loci in conjunction with
RA signaling in the absence of Moz is currently unclear, the
nuclear receptor coactivator 3 (NCOA3/ACTR/KAT13B) associ-
ates with retinoic acid receptors, is a histone acetyltransferase,
and also recruits additional histone acetyltransferases upon ret-
inoic acid and hormone stimulation in a number of human and rat
cell lines (Chen et al., 1997; Torchia et al., 1997). In contrast to
H3K9, there were few or no effects of either Moz or RA on
H3K14 acetylation. In the case of an indirect effect of Moz (or
RA) on transcriptional activation of Hox genes, one would have
expected effects on several activation marks. The specificity of
the action of Moz (and RA) on H3K9, but not on H3K14, and
the direct binding of Ing5, a member of theMoz protein complex,
toHox loci suggest thatMoz directly acetylates H3K9 atHox loci.
Whether Moz is also responsible for acetylation of histone resi-
dues other than H3K9 in vivo at other stages of development
or other loci remains to be examined. Furthermore, it will be inter-
esting to examine occupation of Hox loci by Moz protein, once
ChIP-grade antibodies specific to Moz become available.
The Hoxd4 locus acquires H3 acetylation marks of transcrip-
tionally active loci before onset of transcription during mouse
development (Rastegar et al., 2004). Similarly, H3K9ac and
H3K4me2 were found in the Hoxb9 locus before transcriptional
activation in RA-induced embryonic stem cells (Chambeyron
and Bickmore, 2004). These findings suggest that major regula-
tors of Hox gene expression such as TrxG proteins, previously
perceived as having a maintenance but not an initiation function,
may initiate chromatin changes at Hox loci in mouse develop-
ment even before Hox genes are activated. Our data show that
Moz is required not only for the maintenance of normal Hox
gene expression patterns and levels, but also for very early
Hox gene expression, and they support the idea of a requirement
for Moz and H3K9 acetylation for the onset of gene transcription.
The complex time/space patterns of gene expression neces-
sary for normal development are likely to require multiple epige-
netic signals. H3K9 is a substrate for both acetylation and meth-
ylation, and indeed, in the absence of Moz the transcription
repressive mark, H3K9 trimethylation, is correspondingly
elevated. Acetylation of H3K9 correlates with induction of gene
expression (Agalioti et al., 2002). In contrast, methylation of
H3K9 can lead to the recruitment of silencing proteins (Bannister
et al., 2001; Lachner et al., 2001) and is directly linked to DNA
methylation in a number of human cell lines (Esteve et al.,
2006). Since the presence of acetylation at H3K9 precludes
methylation, the action of Moz in the Hox loci may generate
and stabilize a pattern of chromatin modifications required for
Hox gene expression.
In HeLa cells, the MYST histone acetyltransferase MOF and
the TrxG protein MLL1 are physically associated and act on
the core histones in a coordinated manner, with MLL1 methyl-
ating H3K4 and MOF acetylating H4K16 (Dou et al., 2005). Our
data presented here show that Moz is required for the associa-
tion of Mll1 with Hox gene chromatin. In contrast, H4K16 acety-
lation was not dependent on Moz. We have shown previouslyDevelopmthat Mof specifically acetylates H4K16 and opposes global chro-
matin condensation during mammalian embryonic development
(Thomas et al., 2008). The fact that H4K16 was hyperacetylated
in the absence of Moz suggests that another histone acetyltrans-
ferase, possibly Mof, hyperacetylates H4K16 in the absence
of Moz. Based on our finding presented here, we propose
that Moz and Mll1 act in concert to induce and maintain Hox
gene expression and that Moz is the H3K9-acetyltransferase
opposing the histone deacetylase activity associated with poly-
comb repressor complexes.
In conclusion we have shown that (1) Moz is required for
normal levels and spatially correct Hox gene expression, (2)
Moz is required for correct body segment identity specification
of 19 body segments, and (3) RA rescues the Moz mutant
body segment identity defect. Furthermore we have demon-
strated that (4) Moz is specifically required for the H3K9 acetyla-
tion mark of transcriptionally active Hox gene loci, (5) in the
absence ofMoz the transcriptionally repressive H3K9 trimethyla-
tion mark is propagated, and (6) Moz is required for the presence
of Mll1 and Ing5 at Hox loci.
EXPERIMENTAL PROCEDURES
MozD/+ (Thomas et al., 2006) and Moz+/ (Figure S4) heterozygous mice on
C57BL/6, 129/Sv inbred and FVB/BALB/c hybrid backgrounds were used
for this study. The anterior homeotic transformation of the axial skeleton was
present in Moz mutant pups on all genetic backgrounds. Mice were mated
and examined for vaginal plugs 2 hr after mating (to exclude afternoon
matings) and then daily in the morning. Noon of the morning observation of
a vaginal plug was termed E0.5. Embryos and pups were collected at the
developmental stages indicated in text and figure legends, and extraembry-
onicmembranes were used for genotyping by three-way PCR aswe described
previously (Thomas et al., 2006) and as indicated in Figure S4.
Skeletal preps were conducted as described previously (Thomas et al.,
2000). Whole-mount in situ hybridization was carried out as described
(Thomas et al., 2007). Sense and antisense probes for Moz, Hox genes from
Hoxa1 to a6 and Hoxb2 to b6 and Hoxb8 were used. cRNA probes are listed
in Table S4. Whole-mount immunohistochemistry was performed as
described previously (Loughran et al., 2008). Total RNA isolation, northern
blot analysis, and densitometry were conducted as described previously
(Voss et al., 2000).
Doses for RA treatment were established in pilot experiments. RA in sterile
peanut oil was mixed with powdered mouse feed and replaced the normal
feed. RA feed was consumed within 6 hr after treatment at 8:00 am (2 hr after
the dark/light switch). We tested doses of 5, 10, 20, and 40 mg RA per gram of
bodyweight versus peanut oil treatment without RA. We observed reliable
development of RA-treated pups to E18.5 only at the two lowest doses,
consistent with findings by Kessel and Gruss (1991).
Chromatin immunoprecipitation (ChIP) was carried out according to the
Upstate ChIP protocol (cat# 17-295) with modifications as described in the
Supplemental Experimental Procedures followed by genomic qPCR using
primers listed in Table S5.
Antibodies used for ChIP and immunoblotting were directed against MLL1
(Bethyl A300-086A), ING5 (Abnova H00084289-B01), H3K9ac (Millipore,
Upstate 07-352), H3K14ac (Millipore, Upstate 07-353), H4K16ac (Millipore
P62805), and H3K9me3 (Abcam ab8898). These anti-histone antibodies
detect themodified histone preferentially over other forms of the same histone.
Anti-pan H3 (Millipore, Upstate 05-858) was used as a loading control in immu-
noblotting, and anti-IgG was used as a control in ChIP. Antibodies used for
whole-mount immunohistochemistry and immunofluorescence were directed
against neurofilament (clone 2H3 supplied by T.M. Jessel and J. Dodd to the
Developmental Studies Hybridoma Bank [DSHB], University of Iowa), Hoxb4
(clone I12 supplied by A Gould and R Krumlauf to DSHB) and RARa (Abnova
H5914-M03 1:400).ental Cell 17, 674–686, November 17, 2009 ª2009 Elsevier Inc. 683
Developmental Cell
Moz Is Required for H3K9ac at Hox Gene ClustersTotal protein isolation, SDS polyacrylamide gel electrophoresis, and
western blot analysis were carried out as described previously (Voss et al.,
2003). Immunofluorescence was conducted as described previously (Voss
et al., 2003).
Putative retinoic acid receptor response elements (RARE) near the Hoxa3
and Hoxb3 locus were selected using a Hidden Markov Model-based algo-
rithm published and implemented in a web interface by Sandelin and Wasser-
man (2005) (http://www.cisreg.ca/cgi-bin/NHR-scan/nhr_scan.cgi). We then
examined the sequence conservation of the predicted RARE between human,
mouse, rat, and dog. As the first Hox gene in the Hoxa and the Hoxb cluster
with changes in the anterior expression boundary in Moz mutants was in the
third paralogous group, we selected two putative RARE each in the vicinity
of the Hoxa3 and the Hoxb3 loci, respectively, based on sequence conserva-
tion for ChIP analysis (Table S1).HoxaRARE-1, -2, andHoxbRARE-2 are 100%
conserved between human, dog, mouse, and rat. Ten and twelve of thirteen
bases of HoxbRARE-1 are conserved between humans versus the rodent
species and dog, respectively. HoxbRARE-1 is a perfect consensus RARE
as described (Mangelsdorf et al., 1995; Packer et al., 1998), while the other
three differ by one nucleotide each (Table S1).
Data were analyzed using Intercooled Stata 10 software. Densitometry data
are presented as means ± SEM of densitometry readings and were analyzed
by two or three-factorial analysis of variance (ANOVA) with the number of intact
Moz alleles and animal as two independent factors with or without Hox gene
locus as a third independent factor, followed by Scheffe’s post-hoc test.
ChIP/qPCR data are presented as standardized means ± SEM of DNA
concentration normalized for the housekeeping genes beta-2-microglobulin
(for active marks) or albumin and hemoglobin b1 (for repressive marks) and
were analyzed by one-, two- or three-factorial ANOVA with repeats with
number of intact Moz alleles as the first independent factor, with or without
Hox gene locus as a second independent factor, and with or without retinoic
acid as a third independent factor, followed by Scheffe’s post-hoc test.
Frequencies of numbers of cervical vertebrae in RA-treated versus peanut-
oil-treated or untreated Moz mutants and controls were compared by c2
test. Data in Figure 7 were normalized to untreated wild-type to allow cross-
comparison not just between genotypes, but also between retinoic acid treat-
ment groups. The large number of exact p values corresponding to individual
genomic sites in Figures 5 and 7 are given in Tables S2 and S3 to increase
readability of the text.
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